Latest Breaking News On - Innodem neurosciences - Page 1 : comparemela.com

Eye tracking device for monitoring MS severity approved in Canada

Eye tracking device for monitoring MS severity approved in Canada
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Paul giacominiErin keithDiego mena martMarc reevesInnodem neurosciencesHealth canadaQuebec divisionEye tracking neurological assessmentMultiple sclerosisNovartis canadaPad proExpanded disability status scaleMena mart

INNODEM NEUROSCIENCES ETNAtm-MS OBTAINS HEALTH CANADA S APPROVAL

INNODEM NEUROSCIENCES ETNAtm-MS OBTAINS HEALTH CANADA S APPROVAL
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Erin keithInnodem neurosciencesMarc reevesNeuroscience at novartis pharmaceuticals canada incHealth canadaNovartis pharmaceuticals canada incEye tracking neurological assessmentMultiple sclerosisExpanded disability status scalePad proChief business officerChief executive officerNovartis pharmaceuticals canadaVice president

INNODEM NEUROSCIENCES ETNA™-MS OBTAINS HEALTH CANADA S APPROVAL

Innodem Neurosciences, a leading digital health and AI company, announced today that its ETNA™-MS has been cleared for commercial use by Health Canada. The Eye Tracking Neurological Assessment for Multiple Sclerosis (ETNA™-MS) is a software as a medical device (SaMD, Class II) intended to administer a non-invasive test and provide an Expanded Disability Status Scale (EDSS) score in the range between 1.0 and 4.5 for use in tracking disease progression in MS patients.

Innodem neurosciencesMarc reevesErin keithNovartis pharmaceuticals canada incNeuroscience at novartis pharmaceuticals canada incPad proChief business officerChief executive officerNovartis pharmaceuticals canadaVice presidentEye tracking neurological assessmentEye movementMedical deviceHealth canadaDss scoreI company

Innodem Neurosciences names Chief Medical Officer - Canadian Manufacturing

Dr. Giacomini is a neurologist specializing in multiple sclerosis and neuroinflammatory disorders, as well as advanced neuroimaging techniques.

Innodem neurosciencesPaul giacominiMcgill universityMcgill university health centreMontreal neurological instituteHealth canadaGroup innodem neurosciencesChief medicalMultiple sclerosis clinicAssociate professorData extractionMultiple sclerosis to inform future interventionsPad proNovartis pharma canada

MS news notes: Vaccines, migraines, eye-tracking technology | Multiple Sclerosis News Today

MS news notes: Vaccines, migraines, eye-tracking technology | Multiple Sclerosis News Today
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Marc reevesInnodem neurosciencesDrug administrationEye tracking neurological assessmentNovartis canada